PrediCare is a novel software-based treatment navigation tool, predicting the patient’s disease progression moment. This moment is critical in the patient’s therapeutic timeline, being the key event controlling the change of the treatment plan. PrediCare is designed to be applied in the individual patient treatment course, after each radiological assessment of the tumor, and prior to the next scheduled assessment.


At each radiological assessment, PrediCare allows the physician to act by one of the following scenarios:

  1. If no progression is predicted between the current and next assessment- therapy is continued as usual under the current treatment line;
  2. If a progression event between the current and next assessment is predicted – the physician may choose to (a) immediately switch to next line treatment before a major deterioration in the patient’s state takes place, or (b) call the patient in for an unscheduled (earlier-than-planned) radiological assessment, and upon confirmation of progression – make the switch to next line treatment.

PrediCare allows a switch to the next-line treatment earlier than recommended by the standard of care, leading to improved late-stage treatment navigation. The use of PrediCare is expected to result in extended overall survival, satisfying the goal of all cancer therapeutics for all stake-holders.